Open Access iconOpen Access

ARTICLE

crossmark

H1-antihistamine use and head and neck cancer risk in type 2 diabetes mellitus

YI-NONG CHEN1,#, YING-LIN CHEN1,#, WAN-MING CHEN2,3, MINGCHIH CHEN2,3, BEN-CHANG SHIA2,3, JENQ-YUH KO1,4, SZU-YUAN WU2,3,5,6,7,8,9,10,11,*

1 Department of Otorhinolaryngology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan
2 Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan
3 Artificial Intelligence Development Center, Fu Jen Catholic University, Taipei, Taiwan
4 Department of Otolaryngology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
5 Department of Food Nutrition and Health Biotechnology, College of Medical and Health Science, Asia University, Taichung, Taiwan
6 Division of Radiation Oncology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan
7 Big Data Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan
8 Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung, Taiwan
9 Cancer Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan
10 Centers for Regional Anesthesia and Pain Medicine, Taipei Municipal Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
11 Department of Management, College of Management, Fo Guang University, Yilan, Taiwan

* Corresponding Author: Szu-Yuan Wu, email
# These authors have contributed equally to this study (joint primary authors)

TSP_OR_28449.pdf

  • 1556

    View

  • 645

    Download

  • 0

    Like

Share Link